Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A drug repurposing screen identifies altiratinib as a sel... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A drug repurposing screen identifies altiratinib as a selective inhibitor of a key regulatory splicing kinase and a potential therapeutic for toxoplasmosis and malaria
0
Authors
Christopher Swale
14 more
Christopher Swale
•
Valeria Bellini
12 more
•
Mohamed‐Ali Hakimi
Published
November 3, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Bioinformatics
Ecology
Immunology
Microbiology
Show all topics
DOI
10.1101/2021.11.03.467097
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Bioinformatics
Ecology
Immunology
Microbiology
Show all topics
DOI
10.1101/2021.11.03.467097
License
cc-no
